一段时间以来,科学家和心理健康专家对迷幻药的兴趣越来越大。鉴于专家介绍治疗方法并为患者提供建议,了解他们的观点很重要。因此,我们研究的目的是研究和比较精神病学家和心理学家对迷幻药的态度。我们对它们是如何形成的以及人格在这一过程中的作用感兴趣。我们包括218名受访者,其中92名是精神病学家,126名是心理学家。使用迷幻药问卷上的态度检查了对迷幻药的态度。我们使用五大清单来检查人格特质。关于迷幻药分量表的法律使用,研究表明,精神科医生对迷幻药有更多的消极态度(p=.033)。较高的开放性(β=0.184,p<.001)和较低的责任心(β=-0.144,p=.009)有助于对迷幻药的积极态度,以及以前使用迷幻药的终生经验(β=0.411,p<.001)和较年轻的年龄(β=-0.278,p<.001)。总之,我们可以说,心理健康专业人员是开放的,但也对迷幻药保持警惕。开放激励他们学习。出于这个原因,额外的教育可能会对精神科医生和心理学家的态度产生影响,并为他们实际使用迷幻药做好准备。
For some time now, there has been an increased interest in psychedelics among scientists and mental health experts. Given that experts introduce therapy and advise patients, it is important to know their views. Therefore, the aim of our research was to examine and compare the attitudes of
psychiatrists and psychologists toward psychedelics. We were interested in how they are formed and what is the role of personality in that process. We included 218 respondents, of which 92 were
psychiatrists and 126 were psychologists. Attitudes toward psychedelics were examined using the Attitudes on Psychedelics Questionnaire. We used the Big Five Inventory to examine personality traits. On the Legal Use of Psychedelics subscale, it was shown that
psychiatrists have more negative attitudes toward psychedelics (p = .033). Higher Openness (β = 0.184, p < .001) and lower Conscientiousness (β = -0.144, p = .009) contribute to positive attitudes toward psychedelics, as well as previous lifetime experience with psychedelics (β = 0.411, p < .001) and younger age (β = -0.278, p < .001). In conclusion, we can say that mental health professionals are open but also wary of psychedelics. Openness motivates them to learn. For this reason, additional education could have an impact on the attitudes of
psychiatrists and psychologists and prepare them for the practical use of psychedelics.